Ramucirumab: preclinical research and clinical development.
about
Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis markerTracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncologyRisk of hematological toxicities in patients with solid tumors treated with ramucirumab: a meta-analysis.Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with ramucirumab: a systematic review and meta-analysis.Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumorsTargeted therapies in gastric cancer and future perspectives.Antiangiogenic cancer treatment: The great discovery and greater complexity (Review).An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer.Targeting the VEGF pathway in metastatic bladder cancer.Novel investigational therapies for treating biliary tract carcinoma.Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignancies.Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment.Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy
P2860
Q26771513-57E7CFC6-A6F4-4DBE-A61A-5F844941A6A6Q28085398-65DB3C48-1CEF-40DC-BBB6-F875200A852AQ33426343-F903B67A-CD2B-4566-8ADC-5F3B9A81A179Q35757310-D55F9477-443A-4345-93E0-68C6C1952727Q36296805-D249347D-6A67-4F73-9659-8D70B41B9562Q36471685-1E4ACD53-126B-47E2-8820-02281DC50F64Q37337814-B13C426A-0762-4BE6-BEB9-B7D289001036Q38525073-6EB1A794-02D3-4DAA-9C7A-98AE42743818Q38534167-21821627-28A0-484F-9FE8-27211D4BD187Q38799963-E92ED2C2-BB04-4636-8D58-B96B4413BDB0Q38826507-1E427F2F-B62C-4583-8DAD-3DDDC23E9719Q38852051-5754D808-99FA-4081-8B7C-84307CB9D958Q58547872-97B31311-BA7E-4396-AD79-023FCB3156FA
P2860
Ramucirumab: preclinical research and clinical development.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Ramucirumab: preclinical research and clinical development.
@ast
Ramucirumab: preclinical research and clinical development.
@en
Ramucirumab: preclinical research and clinical development.
@nl
type
label
Ramucirumab: preclinical research and clinical development.
@ast
Ramucirumab: preclinical research and clinical development.
@en
Ramucirumab: preclinical research and clinical development.
@nl
prefLabel
Ramucirumab: preclinical research and clinical development.
@ast
Ramucirumab: preclinical research and clinical development.
@en
Ramucirumab: preclinical research and clinical development.
@nl
P2093
P2860
P356
P1476
Ramucirumab: preclinical research and clinical development
@en
P2093
Caterina Fontanella
Erika Rijavec
Giuseppe Aprile
Karim Rihawi
P2860
P304
P356
10.2147/OTT.S61132
P407
P577
2014-10-29T00:00:00Z